| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
| |
| |
May 31, 2012 |
|
|
| |
|
|
| |
|
|
|
Center for Professional Innovation & Education, Inc., Los Angeles, CA
July 23 & 24, 2012
This course will benefit those involved in the monitoring and/or QA of clinical trials. Upon completion, attendees will be able to identify and define the requirements for GCPs and define the basic roles and responsibilities of sponsor, monitor, investigators and FDA as they relate to the quality of clinical trials. Additionally, the course will detail the similarities and differences in GCPs for drug, device, and biologic studies. Other related issues, such as documentation requirements, data compliance mandates and informed consent protocols will be comprehensively covered. Participants will also learn to apply what they have learned to proactively prevent fraud and misconduct in clinical trials.
|
|
|
|
|
|
|
|
Organized by:
|
|
Center for Professional Innovation & Education |
|
|
Invited Speakers:
|
|
Contact info@cfpie.com for a list of course instructors
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
http://www.cfpie.com/showitem.aspx?productid=043&source=hummolgen
|
|
|
E-mail:
|
|
info@cfpie.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|